ArticleThe oncologist2020

Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.

Marie-France Savard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.